Full text is available at the source.
Abstract
Rapid antidepressant effects from ketamine can occur within hours for treatment-resistant depression.
- The introduction of ketamine has shifted the focus from achieving short-term symptom relief to addressing post-response challenges.
- Key questions involve the durability of initial benefits and strategies for preventing relapse.
- Understanding how to structure and taper maintenance treatment is critical for long-term management.
- There is uncertainty about whether symptom improvement leads to functional recovery.
- Identifying patient characteristics that predict response remains problematic, as reliable biomarkers are still lacking.
- Concerns about the long-term safety and potential for abuse of repeated glutamatergic treatments are ongoing.
Simplified